Atyr Pharma, Inc. · NASDAQ:ATYR
Federated Hermes, Inc. reported a 17.47% stake in Atyr Pharma, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 8, 2025
Federated Hermes, Inc. reported a 17.47% stake in Atyr Pharma, Inc., 14,666,600 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G/A).
- Stake
- 17.47%
- Shares
- 14,666,600
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Federated Hermes, Inc. | 17.47% | 14,666,600 |
| Voting Shares Irrevocable Trust | 17.47% | 14,666,600 |
| Thomas R. Donahue | 17.47% | 14,666,600 |
| Ann C. Donahue | 17.47% | 14,666,600 |
| J. Christopher Donahue | 17.47% | 14,666,600 |
Source
Related
- Atyr Pharma, Inc.
- Federated Hermes, Inc.
- Atyr Pharma, Inc. shareholders
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Jul 8, 2026
- Schedule 13G/A · Federated Hermes, Inc. · Oct 7, 2025
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · Jun 5, 2026
- Form 4 · Schimmel Paul · May 28, 2026
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026